Market Tracker

06/23 5:16pm ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.19
Delayed Data
As of Jun 23
 +0.22 / +7.41%
Today’s Change
2.73
Today|||52-Week Range
6.30
-11.88%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.97
Today’s open2.97
Day’s range2.85 - 3.20
Volume2,103,917
Average volume (3 months)121,787
Market cap$68.5M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+19.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-17.15%
P/E ratioNM
Price/Sales22.39
Price/Book30.12

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll Holdings PL...+0.01+0.44%
IMMYImprimis Pharmaceuti...-0.01-0.30%
DRNADicerna Pharmaceutic...+0.12+3.86%
CXRXConcordia Internatio...-0.11-7.80%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$2.5M
Annual profit (last year)-$38.0M
Net profit margin-1,499.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Daniel N. Swisher
Chief Scientific Officer
Judith A. Fox
Corporate headquarters
South San Francisco, California

Forecasts